Soaring Demand Set to Propel Transcatheter Embolization And Occlusion Devices Market to $7.87 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Transcatheter Embolization And Occlusion Devices Market Through 2025?
The market size for transcatheter embolization and occlusion devices has seen considerable growth in the past few years. The sector, valued at $4.76 billion in 2024, is projected to increase to $5.28 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.9%. Factors that have contributed to its growth during the past period include a growing target patient demographic, a surge in minimally invasive vascular surgeries, a rising number of vascular disease instances, an uptick in chronic diseases, and the demand for efficient treatment alternatives.

What's the Projected Size of the Global Transcatheter Embolization And Occlusion Devices Market by 2029?
In the forthcoming years, the market for transcatheter embolization and occlusion devices is predicted to experience fast-paced expansion, rising to $7.87 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 10.5%. This growth, anticipated within the forecast period, can be traced back to factors such as amplified research and development initiatives, the expansion of the healthcare sector, increased applications of minimally invasive methods, larger elderly demographics, and broader workshops and public awareness. Future trends that will shape the forecast period encompass advancements in technology and imaging, the incorporation of artificial intelligence and machine learning, relentless refinement in device designs, and upgrades in delivery systems.

View the full report here:
https://www.thebusinessresearchcompany.com/report/transcatheter-embolization-and-occlusion-devices-global-market-report

Top Growth Drivers in the Transcatheter Embolization And Occlusion Devices Industry: What's Accelerating the Market?
The increase in popularity of less invasive surgical methods is predicted to fuel the expansion of the transcatheter embolization and occlusion devices market. These less invasive surgeries employ tiny incisions or natural body orifices to cater to internal structures, organs, or tissues with minimal harm to the patient's body. Transcatheter embolization and occlusion devices play a crucial role in these surgeries, as they come with an array of advantages including lowered invasiveness, quicker healing period, local treatment, decreased pain, fewer chances of complications, and the possibility for outpatient procedures. For example, Intuitive Surgical Inc., a US technology firm that specializes in less invasive healthcare products, reported that around 1,875,000 operations were carried out via the Vinci surgical systems in 2022. This marks a growth of around 18% compared to the roughly 1,594,000 operations executed in 2021. Hence, the mounting popularity of less invasive surgical methods fosters the expansion of the transcatheter embolization and occlusion devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15944&type=smp

What Trends Will Shape the Transcatheter Embolization And Occlusion Devices Market Through 2029 and Beyond?
Leading corporations participating in the market for transcatheter embolization and occlusion devices are focused on the creation of high-tech products loaded with features like multi-catheter compatibility. This allows them to provide superior services to clients and carve out a competitive advantage. Multi-catheter compatibility is a boon for healthcare providers as it offers flexibility and effectiveness in conducting transcatheter embolization and occlusion processes with different catheter varieties. To illustrate, in April 2022, Boston Scientific, an American medical product firm, received approval from FDA for its EMBOLD Fibered Detachable Coil, which is crafted for embolization operations in the peripheral vasculature. This gadget forms a part of the firm's interventional oncology array. Its objective is to impede or lessen blood circulation in targeted vessels, thus addressing issues like hemorrhages, aneurysms, tumor reduction, and venous irregularities. The device is endowed with multi-catheter compatibility and employs a nitinol delivery system to avert kinks. This coil thus facilitates smooth procedures, cuts down potential complications, and boosts efficiency.

What Are the Main Segments in the Transcatheter Embolization And Occlusion Devices Market?
The transcatheter embolization and occlusion devices market covered in this report is segmented -

1) By Type: Coil, Non-Coil
2) By Application: Peripheral Vascular Disease, Oncology, Neurology, Urology, Other Applications
3) By End User: Hospitals, Ambulatory Surgical Centers, Clinics, Other End Users

Subsegments:
1) By Coil: Bare Metal Coil, Surface Coated Coil, Detachable Coil
2) By Non-Coil: Gelatin Sponge, Liquid Embolic Agents, Spheres And Particles

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15944&type=smp

Which Top Companies are Driving Growth in the Transcatheter Embolization And Occlusion Devices Market?
Major companies operating in the transcatheter embolization and occlusion devices market are Pfizer Inc., Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic Inc., Stryker Corporation, Boston Scientific Corporation, Edwards Lifesciences Corporation, Terumo Corporation, Teleflex Incorporated, Cook Medical, Merit Medical Systems Inc., Penumbra Inc., AtriCure Inc., Nordion Inc., Sirtex Medical Limited, Cordis Corporation, OpSens Inc., pfm medical ag, Micro Interventional Devices Inc., Acandis GmbH, Metactive Medical Inc.

Which Regions Will Dominate the Transcatheter Embolization And Occlusion Devices Market Through 2029?
North America was the largest region in the transcatheter embolization and occlusion devices market in 2024. The regions covered in the transcatheter embolization and occlusion devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15944

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.